Table 3.
Anthropometric and Laboratory Characteristics at Conclusion and 3-Month Follow-Up Assessments, Pasos Adelante Program, Douglas, Arizona, 2004-2009
| Characteristic | P Valuea | Conclusion (n = 255) | 3-Month Follow-Up (n = 221) | ||
|---|---|---|---|---|---|
| Estimate (SE) | P Valueb | Estimate (SE) | P Valuec | ||
| Anthropometric measure | |||||
| Body mass index | .009 | −0.199 (0.097) | .04 | −0.108 (0.104) | .30 |
| Waist circumference | <.001 | −3.250 (0.301) | <.001 | 0.281 (0.321) | .38 |
| Hip circumference | <.001 | −2.182 (0.230) | <.001 | −0.025 (0.245) | .92 |
| Waist-to-hip ratio | .001 | −0.013 (0.004) | <.001 | 0.004 (0.004) | .34 |
| Systolic blood pressure | .002 | −3.208 (0.918) | <.001 | 2.054 (0.986) | .04 |
| Diastolic blood pressure | <.001 | −2.939 (0.557) | <.001 | 0.789 (0.600) | .19 |
| Pulse | .27 | −0.463 (0.348) | .18 | −0.054 (0.376) | .89 |
| Laboratory measure | |||||
| Total cholesterol | .03 | −6.897 (2.589) | .008 | 4.815 (2.786) | .09 |
| Triglycerides | .94 | 1.448 (8.588) | .87 | 1.236 (9.254) | .89 |
| HDL cholesterol | .12 | −1.105 (0.601 | .07 | 1.229 (0.645) | .06 |
| LDL cholesterol | .24 | −3.906 (2.328) | .09 | 3.165 (2.505) | .21 |
| Glucose | .03 | 0.686 (1.478) | .64 | −4.529 (1.740) | .01 |
Indicates whether time of assessment was significant. Calculated by using the overall model F test.
a
Indicates whether time of assessment was significant.
b
Compared to baseline, calculated by using the t test.
c
Compared to conclusion, calculated by using t test.